The Association of Metabolic Syndrome and Its Components with Electrocardiogram Parameters and Abnormalities Among an Iranian Rural Population: The Fasa PERSIAN Cohort Study

References

• Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215–225. doi:10.1177/1753944717711379
   PubMedGoogle Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. doi:10.2337/diab.37.12.1595
   PubMed Web of Science ®Google Scholar
• Wild SH, Byrne CD. The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. Metab Syndr. 2005;1–41.
   Google Scholar
• Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313(19):1973–1974. doi:10.1001/jama.2015.4260
   PubMed Web of Science ®Google Scholar
• Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A, Kh F. Prevalence of metabolic syndrome in Middle-East countries: meta-analysis of cross-sectional studies. Diabetes Metab Syndr. 2018;12(2):195–201. doi:10.1016/j.dsx.2017.11.004
   PubMed Web of Science ®Google Scholar
• Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251–257. doi:10.1016/j.diabres.2006.12.001
   PubMedGoogle Scholar
• Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003;61(1):29–37. doi:10.1016/S0168-8227(03)00066-4
   PubMedGoogle Scholar
• Grundy S, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
   PubMed Web of Science ®Google Scholar
• Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res. 2009;32(4):289–298. doi:10.1038/hr.2009.14
   PubMed Web of Science ®Google Scholar
• Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–819. doi:10.1016/j.amjmed.2006.02.031
   PubMed Web of Science ®Google Scholar
• Mehta RH, Westerhout CM, Zheng Y, et al. Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non–ST-segment elevation acute coronary syndromes. Am Heart J. 2014;168(2):182–188. e181. doi:10.1016/j.ahj.2014.04.009
   PubMedGoogle Scholar
• Sarrafzadegan N, Mohammadifard N. Cardiovascular disease in iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4).
   PubMedGoogle Scholar
• Naghavi M, Shahraz S, Sepanlou SG, et al. Health transition in Iran toward chronic diseases based on results of global burden of disease 2010. Arch Iran Med. 2014;17(5):321. doi:0141707/AIM.009
   PubMed Web of Science ®Google Scholar
• Queen SR, Smulevitz B, Rentfro AR, et al. Electrocardiographic abnormalities among Mexican Americans: correlations with diabetes, obesity, and the metabolic syndrome. World J Cardiovasc Dis. 2012;2(2):50. doi:10.4236/wjcd.2012.22009
   PubMedGoogle Scholar
• Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol. 2006;47(1):72–75. doi:10.1016/j.jacc.2005.08.052
   PubMed Web of Science ®Google Scholar
• Kors JA, de Bruyne MC, Hoes AW, et al. T axis as an indicator of risk of cardiac events in elderly people. Lancet. 1998;352(9128):601–605. doi:10.1016/S0140-6736(97)10190-8
   PubMedGoogle Scholar
• Rago L, Di Castelnuovo A, Assanelli D, et al. T-wave axis deviation, metabolic syndrome and estimated cardiovascular risk–in men and women of the MOLI-SANI study. Atherosclerosis. 2013;226(2):412–418. doi:10.1016/j.atherosclerosis.2012.11.010
   PubMedGoogle Scholar
• Jiang X, Liu X, Wu S, et al. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study. Heart. 2015;101(1):44–49. doi:10.1136/heartjnl-2014-305685
   PubMed Web of Science ®Google Scholar
• Tokatli A, Kiliçaslan F, Alis M, Yiginer O, Uzun M. Prolonged Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with type 2 diabetes mellitus. Endocrinol Metab. 2016;31(1):105–112. doi:10.3803/EnM.2016.31.1.105
   Google Scholar
• Kuzu F. The effect of type 2 diabetes on electrocardiographic markers of significant cardiac events. Pak J Med Sci. 2018;34(3):626. doi:10.12669/pjms.343.14562
   PubMedGoogle Scholar
• Ahmad MI, Mongraw‐Chaffin M, Lewis KH, Chen H, Ard JD, Soliman EZ. Association of obesity phenotypes with electrocardiographic markers of poor outcomes in the general population. Obesity. 2019;27(12):2076–2083. doi:10.1002/oby.22647
   PubMedGoogle Scholar
• Elffers TW, de Mutsert R, Lamb HJ, et al. Relation of overall and abdominal adiposity with electrocardiogram parameters of subclinical cardiovascular disease in individuals aged 45 to 65 years (from the Netherlands epidemiology of obesity study). Am J Cardiol. 2018;121(5):570–578. doi:10.1016/j.amjcard.2017.11.030
   PubMedGoogle Scholar
• Elffers TW, de Mutsert R, Lamb HJ, et al. Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease. Diabetol Metab Syndr. 2017;9(1):40. doi:10.1186/s13098-017-0238-9
   PubMedGoogle Scholar
• Esteghamati A, Hafezi-Nejad N, Sheikhbahaei S, et al. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study. J Clin Lipidol. 2014;8(3):279–286. doi:10.1016/j.jacl.2014.02.002
   PubMedGoogle Scholar
• Farjam M, Bahrami H, Bahramali E, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: fasa cohort study. BMC Public Health. 2016;16(1):1090. doi:10.1186/s12889-016-3760-z
   PubMedGoogle Scholar
• Woosley R, Heise CW, Romero KA Available from: www.Crediblemeds.org. Accessed Sep 19, 2018.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499
   PubMed Web of Science ®Google Scholar
• Kivimèki M, Lawlor DA, Smith GD, et al. Association of age at menarche with cardiovascular risk factors, vascular structure, and function in adulthood: the cardiovascular risk in young Finns study. Am J Clin Nutr. 2008;87(6):1876–1882. doi:10.1093/ajcn/87.6.1876
   PubMed Web of Science ®Google Scholar
• Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353–370.
   Google Scholar
• Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37(2):161–186. doi:10.1016/0002-8703(49)90562-1
   PubMed Web of Science ®Google Scholar
• Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007;2(4):267–275. doi:10.1111/j.1559-4564.2007.07392.x
   PubMedGoogle Scholar
• Graner M, Pentikäinen M, Siren R, et al. Electrocardiographic changes associated with insulin resistance. Nutr Metab Cardiovasc Dis. 2014;24(3):315–320. doi:10.1016/j.numecd.2013.09.013
   PubMedGoogle Scholar
• Ebong IA, Bertoni AG, Soliman EZ, et al. Electrocardiographic abnormalities associated with the metabolic syndrome and its components: the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord. 2012;10(2):92–97. doi:10.1089/met.2011.0090
   PubMedGoogle Scholar
• Paudyal A, Dev Bhattarai M, Bahadur Karki B, Bajracharya MR, Rajouria AD, Pradhan A. Left axis deviation in electrocardiogram with normal QRS duration in ambulatory adults without cardiac symptoms: a possible marker of glucose intolerance. J Nepal Med Assoc. 2013;52(192). doi:10.31729/jnma.2425
   Google Scholar
• McDonagh E, Rudolph C, Cheraskin E. The relationship of subtle differences in fasting blood glucose with subtle differences in the electrocardiogram: a study of the PR interval. Med Hypotheses. 1982;8(3):261–268. doi:10.1016/0306-9877(82)90122-0
   PubMedGoogle Scholar
• Alonso A, Soliman EZ, Chen LY, Bluemke DA, Heckbert SR. Association of blood pressure and aortic distensibility with P wave indices and PR interval: the multi-ethnic study of atherosclerosis (MESA). J Electrocardiol. 2013;46(4):359.e351–359. e356. doi:10.1016/j.jelectrocard.2013.01.009
   Google Scholar
• Huang Y, Tang S, Chen J-Y, et al. Central aortic systolic blood pressure can predict prolonged QTc duration better than brachial artery systolic blood pressure in rural community residents. Clin Exp Hypertens. 2018;40(3):238–243. doi:10.1080/10641963.2017.1356843
   PubMed Web of Science ®Google Scholar
• 林夏怡, 温似春, 汤松涛, 黄雨晴, 冯颖青. Central aortic systolic blood pressure can better predict prolonged QRS duration than brachial artery systolic blood pressure in rural community residents. South China J Cardiol. 2017;(3):5.
   Google Scholar
• Adegoke SA, Okeniyi JAO, Akintunde AA. Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia. Cardiovasc J Afr. 2016;22(1):16. doi:10.5830/CVJA-2015-059
   Google Scholar
• Del Giorno R, Gabutti S, Troiani C, et al. Association between HDL cholesterol and QTc interval: a population-based epidemiological study. J Clin Med. 2019;8(10):1527. doi:10.3390/jcm8101527
   PubMedGoogle Scholar
• Eisenstein I, Edelstein J, Sarma R, Sanmarco M, Selvester RH. The electrocardiogram in obesity. J Electrocardiol. 1982;15(2):115–118. doi:10.1016/S0022-0736(82)80003-4
   PubMed Web of Science ®Google Scholar
• Landsberg L. Diet, Obesity and Hypertension: An Hypothesis Involving Insulin, the Sympathetic Nervous System, and Adaptive Thermogenesis. Citeseer; 1986.
   Google Scholar
• Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension. Herz Kardiovaskuläre Erkrankungen. 2006;31(4):305–316.
   Google Scholar
• Alpert MA, Terry BE, Cohen MV, Fan TM, Painter JA, Massey CV. The electrocardiogram in morbid obesity. Am J Cardiol. 2000;85(7):908–910. doi:10.1016/S0002-9149(99)00894-2
   PubMed Web of Science ®Google Scholar
• Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study. Obesity. 2012;20(3):666–672. doi:10.1038/oby.2011.53
   PubMed Web of Science ®Google Scholar
• Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88(2):389–419. doi:10.1152/physrev.00017.2007
   PubMed Web of Science ®Google Scholar
• Fox KA, Despres J-P, Richard A-J, Brette S, Deanfield JE. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European Countries. Eur Heart J. 2009;30(24):3055–3063. doi:10.1093/eurheartj/ehp371
   PubMedGoogle Scholar